ArticleKidney international reports2026
Systematic Review of Renal Infarction Clinical Presentation, Causes, and Outcomes.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Renal infarction is rare with only retrospective cohort studies published. To better understand renal infarction, we conducted a systematic review and metaanalysis of proportions for i) incidence and prevalence, ii) patient characteristics and symptoms, iii) causes, and iv) outcomes. Methods: Web of Science, PubMed, and Scopus databases were searched. Articles were screened and data extracted with pooled measures determined by random effects metaanalysis of proportions with 95% confidence interval (95% CI). Heterogeneity was examined through Results: We screened 4010 abstracts and included 34 retrospective cohort studies with 12,727 cases of renal infarction. Pooled incidence was 0.3 per 10,000 patient-years (95% CI, 0.04-2.3; Conclusion: Renal infarction is rare and can present with unspecific symptoms. Antithrombotic use should not exclude renal infarction from the differential and 25% develop CKD. There is a need to better standardize the classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.